Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MHRA advice on rimonabant

The Medicines and Healthcare products Regulatory Agency has issued advice regarding the use of rimonabant (Acomplia®) in patients taking antidepressants or those with major depression. This announcement follows the EMEA review of the safety of this drug.

The risk of psychiatric side effects with rimonabant has caused the MHRA to advise that it should not be prescribed to patients with major depression or those being treated with antidepressants. Evidence suggests that 1 in 10 patients who take rimonabant may develop these psychiatric side effects.

Action: Previous advice placed rimonabant as a last line treatment option. This new advice will further restrict prescribing of this drug to patients who are not taking antidepressants and who have no personal history of depression.

Share 'MHRA advice on rimonabant' on Email Share 'MHRA advice on rimonabant' on Delicious Share 'MHRA advice on rimonabant' on Digg Share 'MHRA advice on rimonabant' on Facebook Share 'MHRA advice on rimonabant' on Google+ Share 'MHRA advice on rimonabant' on reddit Share 'MHRA advice on rimonabant' on StumbleUpon Share 'MHRA advice on rimonabant' on Twitter

atomic-wealth

2 Comments to “MHRA advice on rimonabant”

  1. [...] risk of adverse events and also serious adverse events with rimonabant compared to placebo. Recent advice has indicated that this drug must not be used in patients who are taking antidepressants and who [...]

    Pingback by Prescribing Advice For GPs » MeReC Extra 32 — March 31, 2008 #
    Reply

  2. […] risk of adverse events and also serious adverse events with rimonabant compared to placebo. Recent advice has indicated that this drug must not be used in patients who are taking antidepressants and who […]

    Pingback by MeReC Extra 32 | Prescribing Advice For GPs — March 31, 2008 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,668 spam comments.

atomic-wealth
fond-illness
summer